Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2009 Filed Aug 13, 2009 23:17 UTC |
BALLARD WILLIAM C JRDirector
|
SaleCommon Stock | 10,000 | $28.00 | $280,000.00 |
DisclosureSEC source: 0000731766-09-000077 · edgardoc.xml · nonDerivative · entry 2 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 F1 · price: This transaction was executed in multiple trades, each of which was at the price of $28.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares in each transaction effected. Read SEC document |
| August 13, 2009 Filed Aug 13, 2009 23:17 UTC |
BALLARD WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 10,000 | $5.72 | $57,188.00 |
DisclosureSEC source: 0000731766-09-000077 · edgardoc.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2009 Filed Aug 26, 2009 22:25 UTC |
LEATHERDALE DOUGLAS WDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000078 · edgardoc.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,615 Read SEC document |
| July 30, 2009 Filed Jul 31, 2009 21:58 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 1,602 | $28.10 | $45,016.20 |
DisclosureSEC source: 0000731766-09-000076 · edgardoc.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,095 F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| July 28, 2009 Filed Jul 30, 2009 21:44 UTC |
LEATHERDALE DOUGLAS WDirector
|
SaleCommon Stock | 14,000 | $29.00 | $406,000.00 |
DisclosureSEC source: 0000731766-09-000074 · edgardoc.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,615 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:11 UTC |
BALLARD WILLIAM C JRDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000066 · edgardoc.xml · derivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:11 UTC |
BURKE RICHARD TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000067 · edgardoc.xml · derivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:12 UTC |
DARRETTA ROBERT JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000068 · edgardoc.xml · derivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:12 UTC |
HOOPER MICHELE JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000069 · edgardoc.xml · derivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:12 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000070 · edgardoc.xml · derivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:12 UTC |
RENWICK GLENN MDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000071 · edgardoc.xml · derivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:12 UTC |
Shine Kenneth IrwinDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000072 · edgardoc.xml · derivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 22:13 UTC |
WILENSKY GAIL RDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $25.16 | $0.00 |
DisclosureSEC source: 0000731766-09-000073 · edgardoc.xml · derivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-07-01 Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:18 UTC |
BOUDREAUX GAILEVP & Pres, UnitedHealthcare
|
Tax withholdingCommon Stock | 12,479 | $27.10 | $338,180.90 |
DisclosureSEC source: 0000731766-09-000059 · edgardoc.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,539 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:19 UTC |
Mikan George Lawrence IIIEVP & CFO
|
Tax withholdingCommon Stock | 3,891 | $27.10 | $105,446.10 |
DisclosureSEC source: 0000731766-09-000060 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,518 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:19 UTC |
MUNSELL WILLIAM AEVP & Pres Enterprise Svcs Grp
|
Tax withholdingCommon Stock | 6,718 | $27.10 | $182,057.80 |
DisclosureSEC source: 0000731766-09-000061 · edgardoc.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,229 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:19 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 745 | $27.10 | $20,189.50 |
DisclosureSEC source: 0000731766-09-000062 · edgardoc.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,032 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:19 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 1,490 | $27.10 | $40,379.00 |
DisclosureSEC source: 0000731766-09-000063 · edgardoc.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,136 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:20 UTC |
WELTERS ANTHONYEVP & Pres Publc & Sr Mkts Grp
|
Tax withholdingCommon Stock | 7,210 | $27.10 | $195,391.00 |
DisclosureSEC source: 0000731766-09-000064 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,502 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:20 UTC |
WICHMANN DAVID SEVP & Pres, UHG Operations
|
Tax withholdingCommon Stock | 3,313 | $27.10 | $89,782.30 |
DisclosureSEC source: 0000731766-09-000065 · edgardoc.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,309 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 04, 2009 Filed Jun 4, 2009 20:37 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0000731766-09-000053 · edgardoc.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2009 Filed Jun 4, 2009 20:37 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.61 | $76,094.00 |
DisclosureSEC source: 0000731766-09-000053 · edgardoc.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,529,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2009 Filed Jun 4, 2009 20:37 UTC |
WILENSKY GAIL RDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 860 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0000731766-09-000054 · edgardoc.xml · derivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860 Underlying: Common Stock · 860 shares Expires 2019-06-02 F1 · kind: The reporting person previously elected to convert a portion of her eligible cash compensation into stock options pursuant to a previously approved policy. Read SEC document |
| June 02, 2009 Filed Jun 4, 2009 20:37 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000055 · edgardoc.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,165 F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy. Read SEC document |
| June 02, 2009 Filed Jun 4, 2009 20:37 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,890 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0000731766-09-000056 · edgardoc.xml · derivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Underlying: Common Stock · 1,890 shares Expires 2019-06-02 F1 · kind: The reporting person previously elected to convert eligible cash compensation into stock options pursuant to a previously approved policy. Read SEC document |
| June 02, 2009 Filed Jun 4, 2009 20:38 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000057 · edgardoc.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,620 F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy. Read SEC document |
| June 02, 2009 Filed Jun 4, 2009 20:38 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000058 · edgardoc.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,465 F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy. Read SEC document |
| June 02, 2009 Filed Sep 26, 2009 01:29 UTC Amendment |
BURKE RICHARD TDirector
|
GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-09-045260 · rrd253655.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,529,170 F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy. F2 · balance_after: This amends a Form 4 filed on June 4, 2009 to include shares acquired on June 2, 2009 but not expressly included on the Form 4 originally filed. The shares were correctly included in the total amount of securities beneficially owned as originally reported in Table I, Box 5. This omission was due to a software error. Read SEC document |
| May 27, 2009 Filed May 28, 2009 20:54 UTC |
BALLARD WILLIAM C JRDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0000731766-09-000052 · edgardoc.xml · derivative · entry 2 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2009 Filed May 28, 2009 20:54 UTC |
BALLARD WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.61 | $76,094.00 |
DisclosureSEC source: 0000731766-09-000052 · edgardoc.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2009 Filed May 11, 2009 22:25 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 100,000 | $28.84 | $2,883,600.00 |
DisclosureSEC source: 0000731766-09-000050 · edgardoc.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,518,300 F1 · price: This transaction was executed in multiple trades ranging from $28.69 to $29.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:11 UTC |
BALLARD WILLIAM C JRDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000042 · edgardoc.xml · derivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:11 UTC |
BURKE RICHARD TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000043 · edgardoc.xml · derivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:11 UTC |
DARRETTA ROBERT JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000044 · edgardoc.xml · derivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:12 UTC |
HOOPER MICHELE JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000045 · edgardoc.xml · derivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:12 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000046 · edgardoc.xml · derivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:12 UTC |
RENWICK GLENN MDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000047 · edgardoc.xml · derivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:12 UTC |
Shine Kenneth IrwinDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,167 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000048 · edgardoc.xml · derivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Stock · 3,167 shares Expires 2019-04-01 Read SEC document |
| April 01, 2009 Filed Apr 1, 2009 22:12 UTC |
WILENSKY GAIL RDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0000731766-09-000049 · edgardoc.xml · derivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Read SEC document |
| March 02, 2009 Filed Mar 4, 2009 22:54 UTC |
Sweere LoriEVP, Human Capital
|
PurchaseCommon Stock | 2,880 | $17.42 | $50,166.72 |
DisclosureSEC source: 0000731766-09-000041 · edgardoc.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 2,880 Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:44 UTC |
BOUDREAUX GAILEVP & Pres, UnitedHealthcare
|
GrantStock Appreciation Rights · Derivative | 113,122 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000032 · edgardoc.xml · derivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,122 Underlying: Common Stock · 113,122 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:44 UTC |
BOUDREAUX GAILEVP & Pres, UnitedHealthcare
|
GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000032 · edgardoc.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,017 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:44 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GrantStock Appreciation Rights · Derivative | 169,683 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000033 · edgardoc.xml · derivative · entry 3 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,683 Underlying: Common Stock · 169,683 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:44 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GrantCommon Stock | 57,692 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000033 · edgardoc.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,406,031 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 115,385. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC |
Mikan George Lawrence IIIExec VP & CFO
|
GrantStock Appreciation Rights · Derivative | 113,122 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000034 · edgardoc.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,122 Underlying: Common Stock · 113,122 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC |
Mikan George Lawrence IIIExec VP & CFO
|
GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000034 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Exec VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,406 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC |
MUNSELL WILLIAM AEVP & Pres Enterprise Svcs Grp
|
GrantStock Appreciation Rights · Derivative | 113,122 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000035 · edgardoc.xml · derivative · entry 3 MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,122 Underlying: Common Stock · 113,122 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:45 UTC |
MUNSELL WILLIAM AEVP & Pres Enterprise Svcs Grp
|
GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000035 · edgardoc.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,923 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:46 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantStock Appreciation Rights · Derivative | 28,281 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000036 · edgardoc.xml · derivative · entry 4 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,281 Underlying: Common Stock · 28,281 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:46 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 9,615 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000036 · edgardoc.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,775 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 19,231. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.